Epidermolysis bullosa congenita research hub

Safety and efficacy of allogenic adipose tissue-derived mesenchymal stromal cells in patients with epidermolysis bullosa: Clinical trial phase I/II

This study is testing a new cell treatment for Epidermolysis Bullosa (EB), a skin condition causing fragile skin and blisters. Researchers want to see if these cells, taken from fat tissue, are safe and if they help improve skin healing and reduce symptoms like itching. It's for adults with EB.